Clear Impact logo

Vermont Medicaid

Comprehensive Diabetes Care - Hemoglobin A1c Testing

Current Value

81.39%

2015

Definition

Line Bar

Story Behind the Curve

This composite measure, with 7 different rates, looks at how well Vermont Medicaid cares for the common and serious chronic disease of diabetes. Diabetes is one of the most costly and highly prevalent chronic diseases in the U.S. Many complications, such as amputation, blindness and kidney failure can be prevented if detected and addressed in the early stages.

Vermont Medicaid has developed a care management program, the Vermont Chronic Care Initiative, that helps Medicaid beneficiaries with the most need, including those with diabetes, to better manage their conditions. Please see Partners and Strategies below for more information.

    a.LDL-C Screening

    b.Hemoglobin A1c testing

Rates prior to 2014 were collected through administrative claims only, so are less accurate than the 2014 and 2015 rates which was collected using hybrid (claims + medical record review) methodology.

Partners

  • Vermont Medicaid beneficiaries
  • Medicaid providers and Community Health Teams
  • Vermont Department of Health
  • Vermont Chronic Care Initiative

Action Plan

Vermont Chronic Care Initiative SFY 2013 Annual Report:

http://dvha.vermont.gov/for-providers/1vcci-annual-report-sfy-2013-4-21-14-final-revised-6-26-14.pdf

Vermont Department of Health - Diabetes Prevention and Control:

http://healthvermont.gov/prevent/diabetes/diabetes...

Clear Impact Suite is an easy-to-use, web-based software platform that helps your staff collaborate with external stakeholders and community partners by utilizing the combination of data collection, performance reporting, and program planning.

Scorecard Container Measure Action Actual Value Target Value Tag S A m/d/yy m/d/yyyy